Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.44 |
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | RET | P07949 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31542350 | 0.86 | GPR119 (0.40) | EGLN2GPR119IRAK4RETMAPT | |
| SCHEMBL31542294 | 0.83 | DRD2 (0.37) | EGLN2 | |
| SCHEMBL31542274 | 0.82 | ELANE (0.42) | GPR119 | |
| SCHEMBL31542292 | 0.81 | NOTCH1 (0.36) | GPR119IRAK4RET | |
| SCHEMBL31542319 | 0.80 | ALK (0.35) | ALDH1A1CYP2C19 | |
| SCHEMBL26548555 | 0.80 | MAPT (0.37) | GPR119MAPTMEN1KMT2ANPC1 | |
| SCHEMBL31542300 | 0.79 | GPR119 (0.41) | GPR119IRAK4LMNAALDH1A1 | |
| SCHEMBL31542270 | 0.79 | BRPF1 (0.34) | ALDH1A1 | |
| SCHEMBL31542279 | 0.78 | BRPF1 (0.35) | ALDH1A1CYP2C19 | |
| SCHEMBL26548588 | 0.77 | BRPF1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025062330-A1 | HETEROCYCLIC COMPOUNDS AS CBP SELECTIVE DEGRADERS | AURIGENE ONCOLOGY LIMITED (IN) | 2025-03-27 | — | — | WO | disclosed |